KR102023571B1 - Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient - Google Patents

Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient Download PDF

Info

Publication number
KR102023571B1
KR102023571B1 KR1020190026179A KR20190026179A KR102023571B1 KR 102023571 B1 KR102023571 B1 KR 102023571B1 KR 1020190026179 A KR1020190026179 A KR 1020190026179A KR 20190026179 A KR20190026179 A KR 20190026179A KR 102023571 B1 KR102023571 B1 KR 102023571B1
Authority
KR
South Korea
Prior art keywords
extract
extracts
skin
brown
green tea
Prior art date
Application number
KR1020190026179A
Other languages
Korean (ko)
Inventor
장민정
백성환
편해옥
김현정
안정연
장재윤
김동인
유재묘
Original Assignee
휴먼코스메틱 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 휴먼코스메틱 주식회사 filed Critical 휴먼코스메틱 주식회사
Priority to KR1020190026179A priority Critical patent/KR102023571B1/en
Application granted granted Critical
Publication of KR102023571B1 publication Critical patent/KR102023571B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a skin-whitening cosmetic composition comprising, as active ingredients, one or more extracts from among Tenebrio Molitor extracts, Phyllostachys nigra leaf extracts, and Camellia sinensis leaf extracts. According to the present invention, the skin-whitening cosmetic composition suppresses melanin formation through a mechanism that inhibits the expression of tyrosinase, MITF, TRP-1, and TRP-2, thereby exhibiting skin-whitening effects. In addition, the composition of the present invention comprising the same as an active ingredient may be beneficially used as a material in functional cosmetics for skin whitening without causing skin irritation.

Description

갈색거저리 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물{Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient}Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient}

본 발명은 갈색거저리(Tenebrio Molitor)에서 추출한 갈색거저리 추출물을 유효성분으로 포함하는 기능성 화장료 조성물에 관한 것으로, 보다 구체적으로는 갈색거저리 추출물; 및 대나무잎(Phyllostachys nigra Leaf) 추출물 및 녹차(Camellia sinensis Leaf) 추출물 중 1종 이상의 추출물;을 유효성분으로 포함하는 피부 미백 기능을 갖는 기능성 화장료 조성물에 관한 것이다.The present invention relates to a functional cosmetic composition comprising a brown gourd extract extracted from a brown gourd ( Tenebrio Molitor ) as an active ingredient, more specifically brown gourd extract; And Bamboo Leaves ( Phyllostachys) It relates to a functional cosmetic composition having a skin whitening function comprising as an active ingredient; at least one extract of nigra Leaf extract and Camellia sinensis Leaf extract.

자외선(ultraviolet rays; UV)에 노출되면 피부에서는 활성 산소종(ROS, reactive oxygen species)이 생성되고, 과잉 생성된 활성산소는 산화작용을 일으켜 세포막, DNA 그리고 피부의 주요 구성물질인 지질, 단백질, 다당류 및 핵산과 반응하여 세포에 손상을 주고 피부 노화를 발생시키는 원인이 된다. 이러한 활성산소를 억제하는 성분으로는 butylated hydroxy anisol(BHA), butylated hydroxy toluene(BHT) 등이 알려져 있다. When exposed to ultraviolet rays (UV), the skin produces reactive oxygen species (ROS), and excess free radicals oxidize, causing cell membranes, DNA, and lipids, proteins, Reacts with polysaccharides and nucleic acids to damage cells and cause skin aging. As the components for inhibiting such active oxygen, butylated hydroxy anisol (BHA) and butylated hydroxy toluene (BHT) are known.

또한, UV는 멜라닌 생성을 촉진시키는 것으로 알려져 있는데, 멜라닌은 피부의 색을 결정하는 주요 인자로 자외선에 의해 피부가 자극을 받으면서 표피의 melanocyte에 존재하는 melanocortin 1 receptor(MC1R)와 뇌하수체에서 분비되는 α-melanocyte stimulating hormone(α-MSH)이 결합하여 cyclic adenosine monophosphate(cAMP)/protein kinase A(PKA) 경로에 의해 microphthalmia-associated transcription factor(MITF)의 발현이 증가되면서 형성된다. 또한, 전구물질인 tyrosine 단백질이 tyrosinase라는 효소에 의해 3,4-dihydroxyphenylalanin(L-DOPA)으로 전환되는 가수분해과정과 L-DOPA를 phenylanine-3,4-quinone(DOPA quinone)으로 전환시키는 산화과정을 거쳐 형성된다. 생성된 멜라닌은 피부 중에 침착되어 "검버섯", "주근깨"로 발전하는데, 이것을 방지하기 위하여 다양한 화장품 조성물이 함유된 미백 화장품이 사용되고 있다.In addition, UV is known to promote melanin production. Melanin is a major factor in determining the color of the skin. The melanin is secreted by the melanocortin 1 receptor (MC1R) and the pituitary gland in the melanocytes of the epidermis as the skin is stimulated by UV rays. The combination of -melanocyte stimulating hormone (α-MSH) is formed by increased expression of microphthalmia-associated transcription factor (MITF) by the cyclic adenosine monophosphate (cAMP) / protein kinase A (PKA) pathway. In addition, the hydrolysis process in which the precursor tyrosine protein is converted to 3,4-dihydroxyphenylalanin (L-DOPA) by an enzyme called tyrosinase, and the oxidation process converting L-DOPA to phenylanine-3,4-quinone (DOPA quinone) It is formed through. The resulting melanin is deposited in the skin and develops into "mushrooms" and "freckles". To prevent this, whitening cosmetics containing various cosmetic compositions are used.

갈색거저리(Tenebrio molitor, mealworm)는 딱정벌레목 (Coleoptera) 거저리과로서 한국을 비롯한 전세계에 분포하고 있다. 현재 곤충을 이용한 화장료 조성물 관련 특허로는 귀뚜라미 추출물을 함유하는 피부미백용 화장료 조성물(대한민국 등록특허 제10-1429679호), 누에고치로부터 추출된 세리신 단백질을 함유하는 미용팩조성물(대한민국 등록특허 제10-0542266호) 등이 있으나, 갈색거저리 추출물을 화장료 주성분으로 사용하기 위한 연구는 미미한 실정이다.Brown mealworm ( Tenebrio molitor (mealworm) is a colony of Coleoptera and is distributed all over the world including Korea. Patents related to cosmetic compositions using insects include cosmetic compositions for skin whitening containing cricket extract (Korean Patent No. 10-1429679), and cosmetic pack compositions containing sericin protein extracted from silkworm cocoons (Korean Patent No. 10- 0542266), but studies on the use of brown gourd extract as the main ingredient of cosmetics have been insignificant.

이에 본 발명자들은 생체에 부작용이 없으면서 미백 효과가 우수한 화장품 제조를 위한 새로운 소재로 천연물질을 모색하던 중, 갈색거저리 추출물에 주목하여 그 기능을 실험해 본 결과, 갈색거저리 추출물이 멜라닌 생성 억제 효과가 있음을 발견하였고, 대나무잎 추출물 또는 녹차 추출물과 병용시 그 효과가 증가되는 것을 발견함으로써, 피부 미백을 위한 화장품 천연소재로서의 활용 가능성을 확인하여 본 발명을 완성하였다.The inventors of the present invention, while searching for a natural material as a new material for producing cosmetics with excellent whitening effect without side effects on the living body, and tested the function by focusing on brown edible extract, brown edible extract has a melanin production inhibitory effect It was found that, when used in combination with the bamboo leaf extract or green tea extract was found to increase the effect, confirming the applicability as a cosmetic natural material for skin whitening to complete the present invention.

대한민국등록특허 제10-1429679호Korea Patent Registration No. 10-1429679 대한민국등록특허 제10-0542266호Republic of Korea Patent No. 10-0542266

따라서 본 발명의 목적은 생체에 부작용이 없으면서 피부 미백 효능이 있는 피부 미백용 화장료 조성물을 제공하는 것이다.Therefore, an object of the present invention is to provide a cosmetic composition for skin whitening having no skin side effects and having skin whitening effect.

상기와 같은 본 발명의 목적을 달성하기 위하여, 본 발명은 갈색거저리(Tenebrio Molitor) 추출물; 및 대나무잎(Phyllostachys nigra Leaf) 추출물 및 녹차(Camellia sinensis Leaf) 추출물 중 1종 이상의 추출물;을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다.In order to achieve the object of the present invention as described above, the present invention is brown rice wine ( Tenebrio Molitor ) extract; And Bamboo Leaves ( Phyllostachys) It provides a cosmetic composition for skin whitening containing at least one extract of nigra Leaf) extract and green tea ( Camellia sinensis Leaf) extract as an active ingredient.

본 발명에 따른 갈색거저리 추출물 및 대나무잎 추출물 및 녹차 추출물 중 1종 이상의 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물은 티로시나아제, MITF, TRP-1 및 TRP-2의 발현을 저해하는 기작을 통하여 멜라닌 생성을 억제함으로써 미백 효과를 가지며, 이를 유효성분으로 포함하는 본 발명의 조성물은 피부에 자극을 일으키지 않는 피부 미백을 위한 기능성 화장품의 소재로 유용하게 사용될 수 있을 것이다.The skin composition for skin whitening containing one or more extracts of brown edible extract and bamboo leaf extract and green tea extract according to the present invention has a mechanism of inhibiting the expression of tyrosinase, MITF, TRP-1 and TRP-2. It has a whitening effect by inhibiting the production of melanin, and the composition of the present invention comprising it as an active ingredient may be usefully used as a material of functional cosmetics for skin whitening does not cause skin irritation.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

피부 미백용 For skin whitening 화장료Cosmetics 조성물 Composition

본 발명은 갈색거저리(Tenebrio Molitor) 추출물; 및The present invention brown meal ( Tenebrio Molitor ) extract; And

대나무잎(Phyllostachys nigra Leaf) 추출물 및 녹차(Camellia sinensis Leaf) 추출물 중 1종 이상의 추출물;을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공함에 그 특징이 있다.Bamboo Leaves ( Phyllostachys nigra Leaf) extract and green tea ( Camellia sinensis Leaf) extract of at least one extract; it is characterized by providing a cosmetic composition for skin whitening containing as an active ingredient.

본 발명의 상기 갈색거저리(Tenebrio molitor)는 밀웜(mealworm)이라고도 불리는 것으로, 딱정벌레목(Coleoptera) 거저리과에 속하는 갈색거저리의 유충을 의미하며, 한국을 비롯한 전세계에 분포하고 있다. 주로 애완동물의 먹이로 많이 사용되고 있으며 최근에는 갈색거저리가 대량 생산이 용이한 점과 단백질 등의 영양성분이 풍부한 점을 이용하여 미래의 식량자원으로서 가치도 연구되고 있다. 보고된 연구로는 갈색거저리에서 분리한 항진균단백질을 이용한 항균효과 등이 있으며 동의보감 및 본초강목에는 간경화, 간암, 파상풍 등에 효과가 있는 것으로 알려져 있다. 하지만, 약리적 효능에 대한 연구가 미비하여 다양한 방면에서 탐색이 필요하다. The brown mealworm ( Tenebrio molitor ) of the present invention, also called a worm (mealworm), means a larva of brown mealworms belonging to the Coleoptera mealworm family, is distributed throughout the world, including Korea. It is mainly used as food for pets, and recently, brown gourd is being researched as a value of food resource in the future by using easy mass production and rich in nutrients such as protein. Reported studies include antifungal effects using antifungal proteins isolated from brown rice wine. It is known that eubobogam and herbaceous wood have effects on cirrhosis, liver cancer, and tetanus. However, research on pharmacological efficacy is inadequate and needs to be explored in various ways.

이에, 본 발명자들은 천연물질로부터 유래되어 인체에 안정하면서도, 탁월한 미백 효과를 나타낼 수 있는 소재를 찾고자 모색하던 중, 갈색거저리 추출물에 주목하였으며, 갈색거저리 추출물과 대나무잎 추출물 및 녹차 추출물 중 1종 이상의 추출물을 혼합한 복합물이 이러한 효과를 가지고 있는지 실험을 통해 확인하였다.Thus, the inventors of the present invention, while seeking to find a material that is stable to the human body while showing excellent whitening effect, derived from natural materials, paying attention to brown gourd extract, at least one of brown gourd extract, bamboo leaf extract and green tea extract It was confirmed through experiments whether the complex mixed with the extract has this effect.

한편, 멜라닌은 피부에 존재하는 색소로 자외선 등 외부의 자극으로부터 신체를 보호하는 중요한 기능을 한다. 하지만, 이것이 과잉 생성되어 침착되면 기미나 주근깨 등을 형성시켜 피부 외관상 문제를 야기할 수 있으며 나아가 피부노화를 촉진시키고 피부암을 유발할 수 있기 때문에 멜라닌 과잉생성을 억제할 수 있는 물질의 경우 미백제품으로 사용이 가능하다.On the other hand, melanin is a pigment present in the skin and plays an important role in protecting the body from external stimuli such as ultraviolet rays. However, when it is over-produced and deposited, it can cause blemishes and freckles, which can cause skin appearance problems. Furthermore, it can promote skin aging and cause skin cancer, so it is used as a whitening product for substances that can suppress melanin overproduction. This is possible.

본 발명의 일실시예에 따르면, 본 발명의 갈색거저리 추출물과 대나무잎 추출물 및 녹차 추출물 중 1종 이상의 추출물을 혼합한 복합물이 티로시나아제(tyrosinase)를 농도의존적으로 저해하며, MITF(microphthalmia-associated transcription factor), TRP-1(tyrosinase related protein-1) 및 TRP-2(tyrosinase related protein-2)의 발현을 억제하여 멜라닌 생합성을 억제하는 활성이 있는 것으로 나타났다(실험예 1 내지 5 참조).According to one embodiment of the present invention, the mixture of the brown gourd extract, bamboo leaf extract and green tea extract of the present invention inhibits tyrosinase concentration-dependently, and MITF (microphthalmia-associated) Inhibition of the expression of transcription factor (TRP-1), tyrosinase related protein-1 (TRP-1) and tyrosinase related protein-2 (TRP-2) has been shown to have activity to inhibit melanin biosynthesis (see Experimental Examples 1 to 5).

따라서 티로시나아제 활성 및 멜라닌 생합성을 억제하는 본 발명의 갈색거저리 추출물과 대나무잎 추출물 및 녹차 추출물 중 1종 이상의 추출물을 혼합한 복합물의 경우 피부의 색소 침착 예방 또는 피부의 미백 효과를 위한 용도로 사용될 수 있을 것이다.Therefore, in the case of the composite of the brown gourd extract of the present invention, which inhibits tyrosinase activity and melanin biosynthesis, and one or more extracts of bamboo leaf extract and green tea extract, it may be used for preventing pigmentation of the skin or whitening effect of the skin. Could be.

본 발명에 따른 추출물은 당업계에 공지된 추출하는 방법을 사용하여 천연으로부터 추출하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된 갈색거저리 추출물, 대나무잎 추출물 및 녹차 추출물은 적절한 용매를 이용하여 각각의 원료로부터 추출한 것이며, 예를 들어, 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다. 바람직하게는 갈색거저리, 대나무잎 또는 녹차를 추출한 추출물일 수 있다.The extract according to the present invention may be obtained by extracting from nature using extraction methods known in the art, the brown rice wine extract, bamboo leaf extract and green tea extract as defined in the present invention using an appropriate solvent, respectively It is extracted from the raw materials of, and includes, for example, both crude extracts, polar solvent soluble extracts or nonpolar solvent soluble extracts. Preferably it may be an extract extracted from brown rice wine, bamboo leaves or green tea.

상기 추출물을 추출하기 위한 적절한 용매로는 약학적으로 허용되는 유기용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있으며, 이에 제한되지는 않으나, 예를 들어, 정제수, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다. 바람직하게는 상기 추출물은 아세톤, 에탄올, 메탄올 또는 물 추출물인 것일 수 있고, 더 바람직하게는 에탄올(ethanol), 메탄올(methanol) 또는 물(water) 추출물인 것일 수 있고, 물 추출물인 것이 특히 바람직하다.As a suitable solvent for extracting the extract, any pharmaceutically acceptable organic solvent may be used, and water or an organic solvent may be used, but is not limited thereto. For example, purified water and methanol Alcohols containing 1 to 4 carbon atoms, acetone, ether, benzene, chloroform, including ethanol, propanol, isopropanol, isopropanol, butanol, etc. , Various solvents such as ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or in combination. Preferably the extract may be acetone, ethanol, methanol or water extract, more preferably may be ethanol, methanol or water extract, particularly preferably the water extract. .

추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As the extraction method, any one of hot water extraction method, cold leaching extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be used. In addition, the desired extract may further be subjected to a conventional fractionation process, it may be purified using conventional purification methods. There is no limitation on the preparation method of the extract of the present invention, any known method may be used.

예를 들면, 본 발명의 조성물에 포함되는 갈색거저리, 대나무잎 또는 녹차 추출물은 상기한 용매 추출법으로 추출된 1차 추출물을, 원심분리, 여과, 농축후 동결 건조하여 냉장실에 보관하면서 그대로 사용할 수도 있고, 상기 1차 추출물을 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한, 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography)등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다. For example, the brown gourd, bamboo leaf or green tea extract included in the composition of the present invention may be used as it is while the primary extract extracted by the solvent extraction method is centrifuged, filtered, concentrated and freeze-dried and stored in a refrigerator compartment. In addition, the primary extract may be prepared in a powder state by an additional process such as distillation under reduced pressure and freeze drying or spray drying. In addition, the primary extract is further purified using a variety of chromatography, such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography, etc. You can also get

따라서 본 발명에 있어서 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the extract is a concept including all the extracts, fractions and purified products obtained at each step of extraction, fractionation or purification, their dilutions, concentrates or dried products.

또한, 본 발명자들은 갈색거저리 추출물; 및 대나무 잎 추출물 및 녹차 추출물 중 1종 이상의 추출물의 혼합 비율을 달리하여 복합물을 제조하고 이들의 미백 활성을 확인해 본 결과, 상기 복합물이 모두 미백 효과를 가지고 있으며, 3종의 추출물을 모두 혼합한 복합물이 더욱 우수한 효과를 나타낸다는 것을 실험적으로 입증하였다(실험예 1 내지 5 참조).In addition, the present inventors are brown gourd extract; And a mixture of one or more extracts of bamboo leaf extracts and green tea extracts to prepare a complex and confirm their whitening activity, all of the complexes have a whitening effect, and a mixture of all three extracts It was experimentally demonstrated that this more excellent effect was shown (see Experimental Examples 1 to 5).

본 발명에 따른 화장료 조성물에 있어서, 상기 조성물은 갈색거저리 추출물 50 중량부를 기준으로 대나무잎 추출물 및 녹차 추출물 중 1종 이상의 추출물을 5 내지 55 중량부 포함하는 것일 수 있고, 바람직하게는 8 내지 52 중량부 포함하는 것일 수 있다.In the cosmetic composition according to the present invention, the composition may include 5 to 55 parts by weight of one or more extracts of bamboo leaf extract and green tea extract based on 50 parts by weight of brown gourd extract, and preferably 8 to 52 weight parts. It may be included.

본 발명의 일실시예에 있어서, 상기 조성물은 갈색거저리 추출물 50 중량부를 기준으로 대나무잎 추출물 또는 녹차 추출물 5 내지 55 중량부 포함하는 것일 수 있고, 바람직하게는 대나무잎 추출물 또는 녹차 추출물 45 내지 55 중량부 포함하는 것일 수 있고, 더 바람직하게는 대나무잎 추출물 또는 녹차 추출물 48 내지 52 중량부 포함하는 것일 수 있다.In one embodiment of the present invention, the composition may be one containing 5 to 55 parts by weight of bamboo leaf extract or green tea extract based on 50 parts by weight of brown gourd extract, preferably 45 to 55 weight of bamboo leaf extract or green tea extract It may be included, and more preferably may contain 48 to 52 parts by weight of bamboo leaf extract or green tea extract.

본 발명의 일실시예에 있어서, 상기 조성물은 갈색거저리 추출물 50 중량부를 기준으로 대나무잎 추출물 15 내지 45 중량부 및 녹차 추출물 5 내지 35 중량부 포함하는 것일 수 있고, 바람직하게는 대나무잎 추출물 23 내지 37 중량부 및 녹차 추출물 13 내지 27 중량부 포함하는 것일 수 있고, 더 바람직하게는 대나무잎 추출물 25 내지 35 중량부 및 녹차 추출물 15 내지 25 중량부 포함하는 것일 수 있고, 보다 더 바람직하게는 대나무잎 추출물 28 내지 32 중량부 및 녹차 추출물 18 내지 22 중량부 포함하는 것일 수 있다.In one embodiment of the present invention, the composition may be one containing 15 to 45 parts by weight of bamboo leaf extract and 5 to 35 parts by weight of green tea extract, based on 50 parts by weight of brown gourd extract, preferably from 23 to bamboo leaf extract 37 parts by weight and 13 to 27 parts by weight of green tea extract may be included, and more preferably 25 to 35 parts by weight of bamboo leaf extract and 15 to 25 parts by weight of green tea extract, and more preferably bamboo leaves It may be to include 28 to 32 parts by weight of the extract and 18 to 22 parts by weight of green tea extract.

또한, 본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 본 발명의 화장료 조성물을 첨가할 수 있는 제품으로는, 예를 들어, 수렴화장수, 유연화장수, 영양화장수, 각종크림, 에센스, 팩, 파운데이션 등과 같은 화장품류와 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.In addition, the cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, and as a product to which the cosmetic composition of the present invention may be added, for example, convergent cosmetics, soft cosmetics, nutrient cosmetics , Cosmetics such as various creams, essences, packs, foundations, and cleansing, face wash, soap, treatments, essences and the like.

본 발명의 화장료 조성물의 구체적인 제형으로서는 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 맛사지크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 영양에센스, 팩, 비누, 샴푸, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션, 바디클렌저, 유액, 스틱, 메이컵 베이스, 파운데이션, 프레스파우더, 루스파우더, 아이섀도 등의 제형을 포함하며, 이에 한정되는 것은 아니다.Specific formulations of the cosmetic composition of the present invention include skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, hand cream, essence, nutrition essence, pack, Soap, shampoo, cleansing foam, cleansing lotion, cleansing cream, body lotion, body cleanser, latex, stick, makeup base, foundation, press powder, loose powder, eye shadow and the like, but is not limited thereto.

이하 본 발명을 실시예에 의하여 더욱 상세하게 설명한다. 이들 실시예는 단지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 국한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those skilled in the art that the scope of the present invention is not limited to these examples.

<< 제조예Production Example 1>  1> 갈색거저리Brown meal 추출물의 준비 Preparation of Extract

갈색거저리(Tenebrio Molitor, mealworm)는 에스웜(Sworm, Gyeonggi, Korea)에서 구입하여 물을 시료 중량의 10배의 양으로 첨가한 후, 실온에서 stirrer(250 rpm)를 이용하여 24시간 추출하여 상등액을 분리하였다. 이를 3회 반복 실시한 다음 분리된 상등액을 여과, 농축 및 동결건조하여 갈색거저리 추출물을 제조하였다. 제조된 갈색거저리 추출물은 냉장실에 보관하면서 실험의 시료로 사용하였다(도 1 참조).Brown mealworm ( Tenebrio Molitor and mealworm were purchased from Sworm, Gyeonggi, Korea, and water was added in an amount of 10 times the weight of the sample, followed by extraction with a stirrer (250 rpm) at room temperature for 24 hours to separate the supernatant. This was repeated three times, and the separated supernatant was filtered, concentrated and lyophilized to prepare a brown gourd extract. The prepared brown gourd extract was used as a sample of the experiment while being stored in the refrigerating chamber (see Fig. 1).

<< 제조예Production Example 2> 대나무잎 추출물의 준비 2> Preparation of Bamboo Leaf Extract

건조된 대나무잎(Phyllostachys nigra Leaf)을 시중에서 구입하여 물을 시료 중량의 10배의 양으로 첨가한 후, 실온에서 stirrer(250 rpm)를 이용하여 24시간 동안 추출하여 상등액을 분리하였다. 이를 3회 반복 실시한 다음 분리된 상등액을 여과, 농축 및 동결건조하여 대나무잎 추출물을 제조하였다. 제조된 대나무잎 추출물은 냉장실에 보관하면서 실험의 시료로 사용하였다.Dried Bamboo Leaves ( Phyllostachys nigra Leaf) was purchased commercially and water was added in an amount of 10 times the weight of the sample, followed by extraction for 24 hours using a stirrer (250 rpm) at room temperature to separate the supernatant. This was repeated three times, and the separated supernatant was filtered, concentrated and lyophilized to prepare a bamboo leaf extract. The prepared bamboo leaf extract was used as a test sample while being stored in the refrigerator.

<< 제조예Production Example 3> 녹차 추출물의 준비 3> Preparation of Green Tea Extract

건조된 녹차(Camellia sinensis Leaf)를 시중에서 구입하여 물을 시료 중량의 10배의 양으로 첨가한 후, 실온에서 stirrer(250 rpm)를 이용하여 24시간 동안 추출하여 상등액을 분리하였다. 이를 3회 반복 실시한 다음 분리된 상등액을 여과, 농축 및 동결건조하여 녹차 추출물을 제조하였다. 제조된 녹차 추출물은 냉장실에 보관하면서 실험의 시료로 사용하였다.Dried green tea ( Camellia sinensis Leaf) was purchased on the market, water was added in an amount of 10 times the sample weight, and the supernatant was separated by extraction for 24 hours using a stirrer (250 rpm) at room temperature. This was repeated three times, and the separated supernatant was filtered, concentrated, and lyophilized to prepare a green tea extract. The prepared green tea extract was used as a sample of the experiment while storing in the refrigerator.

<< 실시예Example  And 비교예Comparative example > > 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 제조Of Bamboo, Bamboo Leaf and Green Tea Extracts

상기 제조예 1 내지 3의 갈색거저리 추출물, 대나무잎 추출물 및 녹차추출물을 하기 표 1의 중량부로 혼합하여 실시예 1 내지 12 및 비교예 1 내지 4의 복합물을 제조하였다.To prepare the composite of Examples 1 to 12 and Comparative Examples 1 to 4 by mixing the brown gourd extract, bamboo leaf extract and green tea extract of Preparation Examples 1 to 3 by weight.

갈색거저리 추출물Brown mealworm extract 대나무잎 추출물Bamboo Leaf Extract 녹차 추출물Green tea extract 실시예 1Example 1 5050 2020 2020 실시예 2Example 2 5050 2525 2020 실시예 3Example 3 5050 3030 2020 실시예 4Example 4 5050 3535 2020 실시예 5Example 5 5050 4040 2020 실시예 6Example 6 5050 3030 1010 실시예 7Example 7 5050 3030 1515 실시예 8Example 8 5050 3030 2020 실시예 9Example 9 5050 3030 2525 실시예 10Example 10 5050 3030 3030 실시예 11Example 11 5050 5050 -- 실시예 12Example 12 5050 -- 5050 비교예 1Comparative Example 1 100100 -- -- 비교예 2Comparative Example 2 -- 100100 -- 비교예 3Comparative Example 3 -- -- 100100 비교예 4Comparative Example 4 -- 5050 5050

<< 준비예Preparation > 실험 재료 준비> Preparation of Experimental Materials

미백 효과 측정에 사용된 시약인 mushroom tyrosinase, L-3,4-dihydroxy phenyl-alanine(L-DOPA) 등은 sigma chemical Co. Ltd.(St. Louis, MO, USA)에서 구입하여 사용하였다. cAMP kit(Cayman, Ann Arbor, MI, USA), MITF, Tyrosinase, TRP-1, TRP-2 등의 항체는 santa cruz(Biotech, CA, USA)에서 구입 하였다.Mushroom tyrosinase, L-3,4-dihydroxy phenyl-alanine (L-DOPA), etc., reagents used for measuring the whitening effect, are sigma chemical Co. Ltd. (St. Louis, Mo., USA) and used. Antibodies such as cAMP kit (Cayman, Ann Arbor, MI, USA), MITF, Tyrosinase, TRP-1, TRP-2 were purchased from santa cruz (Biotech, CA, USA).

세포 생존율 측정에 사용된 세포주는 mouse melanoma cell(B16F10)로 american type culture collection(Manassas, VA, USA)에서 구입하여 사용하였다. 세포 배양을 위한 dulbecco's modified eagle medium(DMEM), fetal bovine serum(FBS)은 LONZA Co.에서 구입하여 사용했으며, 0.25% trypsin-EDTA, 0.4% trypan blue stain은 gibco BRL Co.(Grand Island, NY, USA)에서 구입하여 사용하였고, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromid(MTT)는 sigma chemical Co. Ltd.(St. Louis, MO, USA)에서 구입하여 사용하였다.The cell line used for measuring cell viability was obtained from the American type culture collection (Manassas, VA, USA) as a mouse melanoma cell (B16F10). Dulbecco's modified eagle medium (DMEM) and fetal bovine serum (FBS) for cell culture were purchased from LONZA Co., and 0.25% trypsin-EDTA and 0.4% trypan blue stain were used for gibco BRL Co. (Grand Island, NY, USA], 3- [4,5-dimethylthiazol-2-yl] -2,5-diphenyl-tetrazolium bromid (MTT) was obtained from sigma chemical Co. Ltd. (St. Louis, Mo., USA) and used.

본 발명에서 사용된 기기는 UV/VIS spectrophotometer(Hitachi, Japan), polarization microscope(Olympus BX 51, Japan), western imaging system(CAS-400SM, Davinch-K, Korea), rotary vacuum evaporator(Tokyo, Rikakikai Co. Japan), centrifuge(Hitachi, Japan), freeze drier(Ilsin, Korea), microscope(Olympus, Japan), CO2 incubator(Hanbaek Scientific Co., Korea), pH meter(Metrohm. Switzerland), BOD Incubator(Hanbaek Co., Korea), autoclave(Hanbaek Scientific Co., Korea), ELISA reader(Molecular Devices, USA)를 사용하였다.Instruments used in the present invention are UV / VIS spectrophotometer (Hitachi, Japan), polarization microscope (Olympus BX 51, Japan), western imaging system (CAS-400SM, Davinch-K, Korea), rotary vacuum evaporator (Tokyo, Rikakikai Co Japan), centrifuge (Hitachi, Japan), freeze drier (Ilsin, Korea), microscope (Olympus, Japan), CO2 incubator (Hanbaek Scientific Co., Korea), pH meter (Metrohm. Switzerland), BOD Incubator (Hanbaek Co. , Korea), autoclave (Hanbaek Scientific Co., Korea), ELISA reader (Molecular Devices, USA) was used.

<< 실험예Experimental Example 1>  1> 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 티로시나아제(tyrosinase) 저해 활성Tyrosinase Inhibitory Activity of the Complex of Bamboo, Bamboo Leaf and Green Tea Extracts

피부의 색을 결정하는데 영향을 주는 인자 중의 하나인 melanin은 표피의 기저층에 존재하는 melanocyte의 melanosome에서 생합성된다. 이 melanin을 합성하기 위해서는 tyrosine이라는 아미노산의 일종인 물질에서 시작되며 tyrosine은 멜라닌 세포내의 tyrosinase에 의해 L-3,4-dihydroxylphenylalaine(DOPA), DOPA quinone으로 산화된다. DOPA quinone은 DOPA chrome, 5,6-dihydroxyindole, indole-5,6-quinone이 되고 중합반응에 의해 melanin이 생성되는 것으로 알려져 있다[Ko JS. Dermatology. Soomoonsa press. Seoul. Korea. 2000;73., Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980;75(1):122-7., Pavel S, Muskiet FA. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: A preliminary report. Cancer Detect Prev. 1983;6(1-2):311-6.]. 또한 melanin은 활성 산소종(ROS, reactive oxygen species)에 의한 산화반응에 의해서도 합성되는 것으로 알려져 있다[Hachinohe M, Matsumoto H. Involvement of reactive oxygen species generated from melanin synthesis pathway in phytotoxicty of L-DOPA. J Chem Ecol. 2005;31(2):237-46.]. 활성 산소종은 체내 호흡과정 중에 생기는 산물중에 하나인데 과도하게 생성될 경우 melanin 합성 뿐만 아니라 산화적 스트레스를 유발하여 세포손상 및 기관손상을 야기시켜 암, 당뇨, 혈관계질환, 관절염 등과 같은 각종 질병을 유발한다[Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J. 1996;313:17-29.]. 이 같은 이유로 tyrosinase의 저해활성을 확인하는 것은 중요하므로, 본 발명에서는 갈색거저리, 대나무잎 및 녹차 각각의 추출물 및 복합물의 mushroom 유래의 tyrosinase 저해활성을 측정하였다. One of the factors that affect skin color is melanin, which is biosynthesized in the melanocyte melanosomes in the basal layer of the epidermis. To synthesize this melanin, it starts with a kind of amino acid called tyrosine, which is oxidized to L-3,4-dihydroxylphenylalaine (DOPA) and DOPA quinone by tyrosinase in melanocytes. DOPA quinone becomes DOPA chrome, 5,6-dihydroxyindole, indole-5,6-quinone and it is known that melanin is produced by polymerization [Ko JS. Dermatology. Soomoonsa press. Seoul. Korea. 2000; 73., Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980; 75 (1): 122-7., Pavel S, Muskiet FA. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: A preliminary report. Cancer Detect Prev. 1983; 6 (1-2): 311-6.]. Melanin is also known to be synthesized by oxidation by reactive oxygen species (Hachinohe M, Matsumoto H. Involvement of reactive oxygen species generated from melanin synthesis pathway in phytotoxicty of L-DOPA. J Chem Ecol. 2005; 31 (2): 237-46. Reactive oxygen species are one of the products that occur during the respiratory process in the body. When excessively produced, not only melanin synthesis but also oxidative stress causes cell damage and organ damage, resulting in various diseases such as cancer, diabetes, vascular disease, and arthritis. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J. 1996; 313: 17-29.]. For this reason it is important to confirm the inhibitory activity of tyrosinase, in the present invention was measured tyrosinase inhibitory activity derived from the mushrooms of extracts and complexes of brown rice wine, bamboo leaves and green tea.

Tyrosinase 저해활성 측정은 Yagi 등[Yagi A, Kanbara T, Morinobu N. The effect of tyrosinase inhibition for aloe. Planta Med. 1986;3981:517-9.]의 방법에 따라 측정하였다. 반응구는 0.175 M sodium phosphate buffer(pH 6.8) 0.5 mL에 10 mM L-DOPA를 녹인 기질액 0.2 mL및 시료용액 0.1 mL의 혼합액에 mushroom tyrosinase(110 U/mL) 0.2 mL을 첨가하여 25℃에서 2분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475 nm에서 측정하였다. 이때, 양성대조군으로는 butylated hydroxyl anisole(BHA)를 사용하였다. tyrosinase 저해활성은 하기 수학식 1에 나타난 공식을 이용하여 시료용액의 첨가구와 무첨가구(control)의 흡광도 감소율로 나타내었다. 분석 값들은 3회 반복 실험한 값의 mean±S.D.로 나타내었으며, p값이 0.01 미만인 경우 유의한 차이가 있는 것으로 평가하였다(p<0.01).Tyrosinase inhibition activity was measured by Yagi et al. [Yagi A, Kanbara T, Morinobu N. The effect of tyrosinase inhibition for aloe. Planta Med. 1986; 3981: 517-9.]. The reaction zone was prepared by adding 0.2 mL of mushroom tyrosinase (110 U / mL) to a mixture of 0.2 mL of substrate solution dissolved in 10 mM L-DOPA in 0.5 mL of 0.175 M sodium phosphate buffer (pH 6.8) and 0.1 mL of sample solution. The reaction was carried out for a minute to measure the DOPA chrome produced in the reaction solution at 475 nm. At this time, butylated hydroxyl anisole (BHA) was used as a positive control. The tyrosinase inhibitory activity was expressed as the absorbance reduction rate of the addition and non-addition of the sample solution using the formula shown in Equation 1 below. The analytical values were expressed as mean ± S.D. Of three repeated experiments, and were evaluated as having a significant difference when the p value was less than 0.01 (p <0.01).

Figure 112019023370537-pat00001
Figure 112019023370537-pat00001

시료 농도별 tyrosinase 저해율(inhibition rate, %)Inhibition rate of tyrosinase by sample concentration (%) 갈색거저리:대나무잎:녹차Brown meal: Bamboo leaves: Green tea 10μg/mL10 μg / mL 50μg/mL50 μg / mL 100μg/mL100 μg / mL 500μg/mL500 μg / mL 실시예 1Example 1 50:20:2050:20:20 14.114.1 30.230.2 36.636.6 40.440.4 실시예 2Example 2 50:25:2050:25:20 17.017.0 38.938.9 47.347.3 63.963.9 실시예 3Example 3 50:30:2050:30:20 19.219.2 43.643.6 55.355.3 74.874.8 실시예 4Example 4 50:35:2050:35:20 17.817.8 39.539.5 48.548.5 66.466.4 실시예 5Example 5 50:40:2050:40:20 15.215.2 31.631.6 37.937.9 41.741.7 실시예 6Example 6 50:30:1050:30:10 14.314.3 31.231.2 36.236.2 40.940.9 실시예 7Example 7 50:30:1550:30:15 17.217.2 38.738.7 47.447.4 64.764.7 실시예 8Example 8 50:30:2050:30:20 19.219.2 43.643.6 55.355.3 74.874.8 실시예 9Example 9 50:30:2550:30:25 17.617.6 39.339.3 48.148.1 65.665.6 실시예 10Example 10 50:30:3050:30:30 14.914.9 30.730.7 36.536.5 41.541.5 실시예 11Example 11 50:50:050: 50: 0 13.613.6 29.729.7 32.332.3 36.536.5 실시예 12Example 12 50:0:5050: 0: 50 13.713.7 29.229.2 31.931.9 35.135.1 비교예 1Comparative Example 1 100:0:0100: 0: 0 12.312.3 17.917.9 18.218.2 19.619.6 비교예 2Comparative Example 2 0:100:00: 100: 0 7.67.6 12.212.2 14.814.8 17.317.3 비교예 3Comparative Example 3 0:0:1000: 0: 100 7.47.4 10.410.4 13.613.6 16.916.9 비교예 4Comparative Example 4 0:50:500:50:50 10.910.9 18.518.5 20.620.6 24.724.7 양성대조군 (BHA)Positive control group (BHA) -- 12.112.1 47.247.2 81.381.3 91.491.4

그 결과, 갈색거저리, 대나무잎 및 녹차 각각의 단독 추출물을 처리한 비교예 1 내지 3 또는 갈색거저리 추출물을 포함하지 않는 비교예 4 대비 실시예 1 내지 12의 갈색거저리 추출물과 대나무잎 및 녹차 중 1종 이상의 추출물을 혼합한 복합물의 tyrosinase 활성 저해율이 높은 것으로 나타났고, 3종 추출물을 모두 혼합한 실시예 1 내지 10의 복합물을 처리한 군에서 tyrosinase 저해 활성이 더 우수한 것으로 나타났다. As a result, the brown chopped extract, bamboo leaves and green tea of Comparative Examples 1 to 3 or Comparative Example 4 which does not include the brown chopped extract, respectively, treated with brown extract, bamboo leaf and green tea extract 1 The tyrosinase activity inhibition rate of the complexes mixed with more than one species was found to be high, and the tyrosinase inhibitory activity was better in the group treated with the complexes of Examples 1 to 10, in which all three extracts were mixed .

<< 실험예Experimental Example 2>  2> 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 Melanoma cell(B16F10)에 대한 세포 독성Cytotoxicity of Melanoma cell (B16F10) of Complexes of Bamboo, Bamboo Leaf and Green Tea Extracts

갈색거저리, 대나무잎 및 녹차 각각의 추출물 또는 복합물에 의한 melanoma cell의 생존율은 Carmichael[Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 1987;47(4):936-42.]의 방법에 따라 MTT assay로 측정하였다.The survival rate of melanoma cells by extracts or complexes of brown mealworms, bamboo leaves, and green teas was evaluated by Carmichael [Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 1987; 47 (4): 936-42.] Was measured by the MTT assay.

구체적으로, 세포주 B16F10 cell을 96 well plate에 5×104 cells/well이 되게 0.18 mL 분주하고, 시료를 농도별(10, 50, 100 및 500 μg/mL)로 조제하여 0.02 mL 첨가한 후 37℃, 5% CO₂incubator에서 24시간 배양하였다. 여기에 5 mg/mL 농도로 제조한 MTT 용액 0.02 mL 첨가하여 4시간 배양한 후 배양액을 제거하고 각 well당 DMSO 0.15 mL를 가하여 실온에서 30분간 반응시킨 뒤 ELISA reader로 540nm에서 흡광도를 측정하였다. 세포 독성 측정은 하기 수학식 2에 나타난 공식을 이용하여 시료용액의 첨가군와 무첨가군의 흡광도 감소율로 나타내었으며, 분석 값들은 3회 반복 실험한 값의 mean±S.D.로 나타내었고, p값이 0.01 미만인 경우 유의한 차이가 있는 것으로 평가하였다(p<0.01).Specifically, 0.18 mL of the cell line B16F10 cells were dispensed in a 96 well plate at 5 × 10 4 cells / well, and the sample was prepared by concentration (10, 50, 100 and 500 μg / mL), and then added 0.02 mL 37 It was incubated for 24 hours in a 5% CO₂incubator. After incubation for 4 hours by adding 0.02 mL of MTT solution prepared at a concentration of 5 mg / mL, the culture solution was removed, and 0.15 mL of DMSO was added to each well for 30 minutes at room temperature, and the absorbance was measured at 540 nm with an ELISA reader. Cytotoxicity measurement was expressed as the absorbance reduction rate of the sample solution addition group and no addition group using the formula shown in Equation 2 below, the analysis values were expressed as mean ± SD of three repeated experiments, p value is less than 0.01 There was a significant difference (p <0.01).

Figure 112019023370537-pat00002
Figure 112019023370537-pat00002

그 결과, 농도 10, 50 및 100 μg/mL에서 모두 95% 이상의 생존율을 보여 실험 구간으로 설정하였다.As a result, the survival rate of more than 95% at all 10, 50 and 100 μg / mL concentration was set as the experimental section.

<< 실험예Experimental Example 3>  3> 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 Melanoma cell(B16F10)에서 티로시나아제(tyrosinase) 저해 활성Inhibitory Activity of Tyrosinase in Melanoma Cell (B16F10)

B16F10 cell을 각 culture dish에 가득 배양 한 후, 배지를 제거하고 PBS로 세척하였다. 각 dish에 lysis buffer(67 mM sodium phosphate buffer, 1% triton X-100, 0.1 mM phenylmethyl sulfonyfluoride)를 100 μL 첨가한 후 얼음에 방치하고 다시 세포를 수집하여 ultra sonication 하였다. 이를 1시간 동안 방치한 후 13,200 rpm에서 20분간 원심분리 하여 얻어진 상층액을 효소용액으로 사용하였다. 이를 67 mM phosphate buffer(pH 6.8)에 녹인 8.0 mM의 L-DOPA 120 μL와 농도별(10, 50 및 100 μg/mL) 시료용액 40 μL를 96 well plate에 넣은 후, 67 mM phosphate buffer(pH 6.8)에 녹인 효소용액 40 μL을 첨가하여 37℃에서 30분간 배양한 후, 생성된 DOPA chrome의 양을 490nm에서 측정하였다. 이때 분석 값들은 3회 반복 실험한 값의 mean ± S.D.로 나타내었다.After culturing B16F10 cells in each culture dish, the medium was removed and washed with PBS. 100 μL of lysis buffer (67 mM sodium phosphate buffer, 1% triton X-100, 0.1 mM phenylmethyl sulfonyfluoride) was added to each dish, and the cells were left on ice and ultra sonicated by collecting cells. After standing for 1 hour, the supernatant obtained by centrifugation at 13,200 rpm for 20 minutes was used as an enzyme solution. 120 μL of 8.0 mM L-DOPA dissolved in 67 mM phosphate buffer (pH 6.8) and 40 μL of sample solution (10, 50 and 100 μg / mL) were added to a 96 well plate, followed by 67 mM phosphate buffer (pH). 6.8) was added and 40 μL of the enzyme solution dissolved therein was incubated at 37 ° C. for 30 minutes, and the amount of DOPA chrome produced was measured at 490 nm. The analytical values are expressed as mean ± S.D. of three repeated experiments.

시료 농도별 티로시나아제 활성(tyrosinase activity, %)Tyrosinase activity (%) by sample concentration 갈색거저리:대나무잎:녹차Brown meal: Bamboo leaves: Green tea 10μg/mL10 μg / mL 50μg/mL50 μg / mL 100μg/mL100 μg / mL 무첨가군 (Con)No additive group (Con) -- 100.0100.0 100.0100.0 100.0100.0 실시예 1Example 1 50:20:2050:20:20 92.892.8 69.969.9 56.556.5 실시예 2Example 2 50:25:2050:25:20 86.186.1 62.662.6 48.848.8 실시예 3Example 3 50:30:2050:30:20 82.982.9 57.557.5 44.844.8 실시예 4Example 4 50:35:2050:35:20 85.385.3 61.161.1 48.148.1 실시예 5Example 5 50:40:2050:40:20 92.292.2 67.567.5 55.655.6 실시예 6Example 6 50:30:1050:30:10 92.892.8 69.169.1 56.256.2 실시예 7Example 7 50:30:1550:30:15 85.985.9 62.062.0 48.448.4 실시예 8Example 8 50:30:2050:30:20 82.982.9 57.557.5 44.844.8 실시예 9Example 9 50:30:2550:30:25 85.585.5 61.861.8 47.947.9 실시예 10Example 10 50:30:3050:30:30 92.292.2 68.468.4 55.755.7 실시예 11Example 11 50:50:050: 50: 0 93.593.5 71.471.4 63.863.8 실시예 12Example 12 50:0:5050: 0: 50 93.993.9 72.372.3 65.265.2 비교예 1Comparative Example 1 100:0:0100: 0: 0 96.696.6 83.683.6 78.278.2 비교예 2Comparative Example 2 0:100:00: 100: 0 97.397.3 88.888.8 83.783.7 비교예 3Comparative Example 3 0:0:1000: 0: 100 97.697.6 88.788.7 84.684.6 비교예 4Comparative Example 4 0:50:500:50:50 95.495.4 80.680.6 74.874.8

상기 방법에 따라 실시예 1 내지 12 및 비교예 1 내지 4의 갈색거저리, 대나무잎 및 녹차 각각의 추출물 또는 복합물에 의한 melanoma cell에서의 티로시나아제(tyrosinase) 저해활성을 확인한 결과, 상기 표 3에 나타난 바와 같이, 비교예 1 내지 4의 단독 추출물 또는 복합물 대비 갈색거저리 추출물 및 대나무잎 및 녹차 중 1종 이상을 혼합한 실시예 1 내지 12의 복합물의 tyrosinase 저해 활성이 높은 것으로 나타났다. 또한, 2종을 혼합한 실시예 11 및 12의 복합물보다 3종을 모두 혼합한 실시예 1 내지 10의 복합물이 tyrosinase 활성을 더 감소시키는 것으로 나타났으며, 농도 100 μg/mL에서 실시예3=실시예8>실시예9>실시예4>실시예7>실시예2>실시예5>실시예10>실시예6>실시예1 순으로 tyrosinase 저해 활성이 우수하게 나타났다. As a result of confirming the tyrosinase inhibitory activity in melanoma cells by the extracts or complexes of brown rice wine, bamboo leaves and green tea of Examples 1 to 12 and Comparative Examples 1 to 4 according to the above method, As shown, the tyrosinase inhibitory activity of the complexes of Examples 1 to 12 mixed with brown gourd extract and bamboo leaves and green tea compared to the extracts or the complexes of Comparative Examples 1 to 4 alone or one of the complexes was higher. In addition, it was shown that the complexes of Examples 1 to 10, in which all three species were mixed, compared to the complexes of Examples 11 and 12, which mixed two species, further reduced tyrosinase activity. Example 8> Example 9> Example 4> Example 7> Example 2> Example 5> Example 10> Example 6> Example 1 In the order of tyrosinase inhibitory activity was excellent.

<< 실험예Experimental Example 4>  4> 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 Melanoma cell(B16F10)에서 멜라닌(melanin) 생합성 저해활성Inhibitory Activity of Melanin Biosynthesis in Melanoma Cell (B16F10)

B16F10 cell에서 melanin 생합성 저해 측정은 Hosoi 등[Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 1985;45(4):1474-8.]의 방법에 따라 측정하였다. DMEM 배지로 배양된 B16F10 cell을 100mm culture dish에 1×10 cells/dish가 되게 분주하고 24시간 배양 후 시료를 농도별로 조제하여 2 mL 첨가하고, 48시간 후에 인산완충액(pH 7.4)으로 세척하였다. 그 다음 0.25 M trypsin-EDTA 용액으로 세포를 탈착한 후 수확한 세포를 1×10 cell 당 1 mL의 5% TCA로 처리하고, 2,500 rpm으로 2회 원심분리한 후 분리된 melanin을 인산완충액으로 세척한 뒤 ether:ethanol(1:3) 1 mL를 가하여 2회 원심분리한 후 ether 1 mL로 세척 건조시켰다. 건조된 melanin에 1 N NaOH를 1 mL 가하여 80℃에서 1시간 반응시킨 후 405 nm에서 흡광도를 측정하였다. Melanin 생합성 저해는 하기 수학식 3에 나타난 공식을 이용하여 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었으며, 분석 값들은 3회 반복 실험한 값의 mean ± S.D.로 나타내었다.Measurement of melanin biosynthesis inhibition in B16F10 cells is described by Hosoi et al. [Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 1985; 45 (4): 1474-8.]. B16F10 cells incubated in DMEM medium were dispensed to 1 × 10 cells / dish in a 100mm culture dish, and cultured for 24 hours, 2 mL of the samples were prepared by concentration, and washed 48 hours later with phosphate buffer (pH 7.4). Then, the cells were detached with 0.25 M trypsin-EDTA solution, and the harvested cells were treated with 1 mL of 5% TCA per 1 × 10 cell, centrifuged twice at 2,500 rpm, and the separated melanin was washed with phosphate buffer. Then, 1 mL of ether: ethanol (1: 3) was added thereto, followed by centrifugation twice, followed by washing with 1 mL of ether and drying. 1 mL of 1 N NaOH was added to the dried melanin and reacted at 80 ° C. for 1 hour, and then the absorbance was measured at 405 nm. Melanin biosynthesis inhibition was expressed as the absorbance decrease rate of the sample solution addition group and no addition group using the formula shown in Equation 3 below, and the analysis values were expressed as mean ± S.D. of three repeated experiments.

Figure 112019023370537-pat00003
Figure 112019023370537-pat00003

시료 농도별 멜라닌(melanin) 생합성 저해율(%)Melanin biosynthesis inhibition rate (%) by sample concentration 갈색거저리:대나무잎:녹차Brown meal: Bamboo leaves: Green tea 10μg/mL10 μg / mL 50μg/mL50 μg / mL 100μg/mL100 μg / mL 무첨가군 (Con)No additive group (Con) -- 100.0100.0 100.0100.0 100.0100.0 실시예 1Example 1 50:20:2050:20:20 3.13.1 30.830.8 36.436.4 실시예 2Example 2 50:25:2050:25:20 5.25.2 42.642.6 47.147.1 실시예 3Example 3 50:30:2050:30:20 7.27.2 45.745.7 50.250.2 실시예 4Example 4 50:35:2050:35:20 5.65.6 43.643.6 47.847.8 실시예 5Example 5 50:40:2050:40:20 3.73.7 32.132.1 37.337.3 실시예 6Example 6 50:30:1050:30:10 3.33.3 31.631.6 36.736.7 실시예 7Example 7 50:30:1550:30:15 5.55.5 42.842.8 47.147.1 실시예 8Example 8 50:30:2050:30:20 7.27.2 45.745.7 50.250.2 실시예 9Example 9 50:30:2550:30:25 5.75.7 43.243.2 47.047.0 실시예 10Example 10 50:30:3050:30:30 3.63.6 31.831.8 37.237.2 실시예 11Example 11 50:50:050: 50: 0 3.43.4 28.628.6 33.133.1 실시예 12Example 12 50:0:5050: 0: 50 3.03.0 28.428.4 32.832.8 비교예 1Comparative Example 1 100:0:0100: 0: 0 0.80.8 14.214.2 18.218.2 비교예 2Comparative Example 2 0:100:00: 100: 0 1.41.4 16.216.2 16.416.4 비교예 3Comparative Example 3 0:0:1000: 0: 100 1.11.1 15.315.3 15.715.7 비교예 4Comparative Example 4 0:50:500:50:50 2.12.1 21.921.9 25.425.4

실시예 1 내지 12 및 비교예 1 내지 4의 갈색거저리, 대나무잎 및 녹차 각각의 추출물 또는 복합물에 의한 melanoma cell에서의 melanin 생합성 저해활성을 측정하기 위하여, 농도별로 확인한 결과, 상기 표 4에 나타난 바와 같이, tyrosinase저해 활성 결과와 마찬가지로 비교예 1 내지 4의 단독 추출물 또는 갈색거저리 미포함 복합물 대비 갈색거저리 추출물과 대나무잎 녹차 중 1종 이상의 추출물을 혼합한 실시예 1 내지 12의 복합물의 melanin 생합성 저해 활성이 높은 것으로 나타났다. 또한, 2종을 혼합한 실시예 11 및 12의 복합물보다 3종을 모두 혼합한 실시예 1 내지 10의 복합물을 처리한 경우에 melanin 함량이 더 감소된 것으로 나타났으며, 농도 100 μg/mL에서 실시예3=실시예8>실시예4>실시예2>실시예7>실시예9>실시예5>실시예10>실시예6>실시예1 순으로 melanin 생합성을 감소하는 효과가 우수하게 나타났다. In order to measure the melanin biosynthesis inhibitory activity in melanoma cells by extracts or complexes of brown rice wine, bamboo leaves and green tea of Examples 1 to 12 and Comparative Examples 1 to 4, the results were confirmed by concentration, as shown in Table 4 above. Likewise, the melanin biosynthesis inhibitory activity of the complexes of Examples 1 to 12, which were mixed with brown extracts and one or more extracts of bamboo leaf green tea, compared to the extracts of Comparative Examples 1 to 4 or the complex containing no brown meals, as in the results of tyrosinase inhibition activity Found to be high. In addition, it was found that the melanin content was further reduced when the complexes of Examples 1 to 10, which were mixed with all three species, were mixed, compared to the complexes of Examples 11 and 12, which were mixed with two species. Example 3 Example 8> Example 4> Example 2> Example 7> Example 9> Example 5> Example 10> Example 6> Example 1 The effect of reducing melanin biosynthesis was excellent in this order. appear.

<< 실험예Experimental Example 5>  5> 갈색거저리Brown meal , 대나무잎 및 녹차 추출물의 복합물의 Western blot을 통한 티로시나아제(tyrosinase), MITF, TRP-1, TRP-2 발현 억제 효과Inhibitory Effects of Tyrosinase, MITF, TRP-1, and TRP-2 Expression on Western Blot of Complex of Bamboo, Leaf and Green Tea Extracts

멜라닌 생성은 주로 산화적 반응에 의해서 일어나는데 TRP-1은 TRP-2에 의해 생성된 5,6-dihydroxy indole-2-carboxylic acid(DHICA)를 oxidation 시켜 indole-2-carboxylic acid(IQCA)를 생성한다. microphthalmia-associated transcription factor(MITF)는 tyrosinase의 발현을 조절하는 인자이다. 따라서 MITF의 억제는 tysinase의 발현을 억제시키며 결과적으로 melanin 색소의 생성을 억제할 수 있다.Melanin production occurs mainly by oxidative reactions. TRP-1 oxidizes 5,6-dihydroxy indole-2-carboxylic acid (DHICA) produced by TRP-2 to produce indole-2-carboxylic acid (IQCA). . Microphthalmia-associated transcription factor (MITF) is a factor that regulates the expression of tyrosinase. Therefore, inhibition of MITF inhibits tysinase expression and consequently inhibits melanin pigment production.

실시예 3(=실시예 8)의 갈색거저리, 대나무잎 및 녹차 추출물의 복합물이 tyrosinase, MITF, TRP-1, TRP-2의 발현에 미치는 영향을 보기 위해 mouse melanoma cell(B16F10)에 상기 복합물을 10, 25, 50, 100 μg/mL 의 농도로 처리한 후 48시간 뒤에 회수하여 western blot을 통해 상기 단백질들의 발현을 확인하였다. The complex of Example 3 (= Example 8) brown mouse, bamboo leaf and green tea extract to the expression of tyrosinase, MITF, TRP-1, TRP-2 in the mouse melanoma cell (B16F10) After treatment at a concentration of 10, 25, 50, 100 μg / mL and recovered after 48 hours, the expression of the proteins was confirmed by western blot.

구체적으로, cell을 차가운 PBS로 2회 세척 후 RIPA buffer 10 mL에 complate mini 1 tab을 가한 것으로 용해해서 4℃ 12,000 rpm에서 15분간 원심 분리 하였다. 원심 분리하여 얻은 상층액은 bradford assay로 정량하여 25 μL의 단백질을 10%의 SDS-PAGE 에서 전기 영동하여 분리하였다. 분리된 단백질은 semi dry transfer cell(Hofer, USA) 기기를 이용하여 PVDF membrane에 옮긴 다음 실온에서 30분 동안 blocking buffer(5% skim milk in TBST)에서 incubation 시켰다. 1차 항체를 희석하여 3시간 동안 반응한 다음, 다시 10분 간격으로 TBST로 3회 washing 하고 membrane을 HRP가 중합된 각각의 2차 항체를 1:1,000로 희석하여 60분 동안 반응시켰다. 3회 washing 한 뒤 davinch-k western imaging system 기기를 이용하여 밴드 확인 및 정량하였다. 분석 값들은 3회 반복 실험한 값의 mean ± S.D.로 나타내었고, 분석 대상에 따라 p값이 0.01 또는 0.05 미만인 경우 유의한 차이가 있는 것으로 평가하였다(p<0.01 or 0.05). House keeping gene으로는 β-actin을 사용하였다. Specifically, the cells were washed twice with cold PBS, dissolved by adding complate mini 1 tab to 10 mL of RIPA buffer, and centrifuged at 12,000 rpm for 15 minutes at 4 ° C. The supernatant obtained by centrifugation was quantified by bradford assay and 25 μL of protein was separated by electrophoresis on 10% SDS-PAGE. The separated proteins were transferred to PVDF membrane using a semi dry transfer cell (Hofer, USA) and incubated in blocking buffer (5% skim milk in TBST) for 30 minutes at room temperature. After diluting the primary antibody and reacting for 3 hours, the mixture was washed three times with TBST at 10 minute intervals and the membrane was reacted for 60 minutes by diluting each secondary antibody polymerized with HRP at 1: 1,000. After washing three times, the band was identified and quantified using a davinch-k western imaging system. The analytical values were expressed as mean ± S.D. of three repeated experiments, and it was evaluated that there was a significant difference when the p value was less than 0.01 or 0.05 depending on the analysis target (p <0.01 or 0.05). Β-actin was used as house keeping gene.

시료(실시예 3) 농도별 단백질 발현량(%)Sample amount (%) of protein expression by concentration ConCon 10μg/mL10 μg / mL 25μg/mL25 μg / mL 50μg/mL50 μg / mL 100μg/mL100 μg / mL Tyrosinase/β-actin ratioTyrosinase / β-actin ratio 100.0100.0 85.685.6 71.371.3 66.866.8 58.458.4 MITF/β-actin ratioMITF / β-actin ratio 100.0100.0 99.899.8 98.298.2 95.495.4 87.587.5 TRP-1/β-actin ratioTRP-1 / β-actin ratio 100.0100.0 58.558.5 30.730.7 14.614.6 7.17.1 TRP-2/β-actin ratioTRP-2 / β-actin ratio 100.0100.0 78.478.4 41.641.6 24.324.3 13.813.8

그 결과, 상기 표 5에 나타난 바와 같이, tyrosinase, MITF, TRP-1 및 TRP-2 모두 농도의존적으로 발현이 감소하는 경향을 보여, 실시예 3(=실시예 8)의 갈색거저리, 대나무잎 및 녹차 추출물의 복합물이 상기 인자들의 발현을 저해하여 티로시나아제 활성 저해 및 멜라닌 생합성 저해 효과를 나타낼 수 있음을 확인하였다.As a result, as shown in Table 5, all of tyrosinase, MITF, TRP-1 and TRP-2 showed a tendency to decrease the expression depending on the concentration, brown meal, bamboo leaf and Example 3 (= Example 8) It was confirmed that the complex of green tea extracts may inhibit the expression of the factors and have an inhibitory effect on tyrosinase activity and melanin biosynthesis.

따라서, 종합적으로 본 발명자들은 이러한 결과들을 토대로 본 발명의 갈색거저리, 대나무잎 및 녹차 추출물의 복합물을 미백 활성을 갖는 화장료 조성물로 사용할 수 있음을 확인하였다. Therefore, based on these results, the present inventors confirmed that the composite of brown rice meal, bamboo leaf and green tea extract of the present invention can be used as a cosmetic composition having a whitening activity.

이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far I looked at the center of the preferred embodiment for the present invention. Those skilled in the art will appreciate that the present invention can be implemented in a modified form without departing from the essential features of the present invention. Therefore, the disclosed embodiments should be considered in descriptive sense only and not for purposes of limitation. The scope of the present invention is shown in the claims rather than the foregoing description, and all differences within the scope will be construed as being included in the present invention.

Claims (3)

갈색거저리(Tenebrio Molitor) 추출물 50중량부 기준;
대나무잎(Phyllostachys nigra Leaf) 추출물 25-35 중량부; 및
녹차(Camellia sinensis Leaf) 추출물 15-25 중량부;
를 유효성분으로 함유하는 피부 미백용 화장료 조성물.
Based on 50 parts by weight of Tenebrio Molitor extract;
25-35 parts by weight of Phyllostachys nigra Leaf extract; And
15-25 parts by weight of green tea ( Camellia sinensis Leaf) extract;
Cosmetic composition for skin whitening containing as an active ingredient.
제 1항에 있어서,
상기 추출물은 에탄올(ethanol), 메탄올(methanol) 또는 물(water) 추출물인 것을 특징으로 하는 피부 미백용 화장료 조성물.
The method of claim 1,
The extract is a skin whitening cosmetic composition, characterized in that the ethanol (ethanol), methanol (methanol) or water (water) extract.
삭제delete
KR1020190026179A 2019-03-07 2019-03-07 Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient KR102023571B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190026179A KR102023571B1 (en) 2019-03-07 2019-03-07 Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190026179A KR102023571B1 (en) 2019-03-07 2019-03-07 Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient

Publications (1)

Publication Number Publication Date
KR102023571B1 true KR102023571B1 (en) 2019-09-24

Family

ID=68069003

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190026179A KR102023571B1 (en) 2019-03-07 2019-03-07 Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient

Country Status (1)

Country Link
KR (1) KR102023571B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230061929A (en) 2021-10-29 2023-05-09 대한민국(환경부 국립생물자원관장) Novel Bacillus endophyticus S2-11 strain

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100542266B1 (en) 2003-08-04 2006-01-11 한국식품연구원 Face-pack Composition Comprising Sericin Protein Extracted from Cocoon
KR20110078559A (en) * 2009-12-31 2011-07-07 신면호 Skin care cosmetic composition
KR101429679B1 (en) 2012-05-30 2014-08-13 경북대학교 산학협력단 Cosmetic compositions for skin whitening comprising cricket extracts
KR20180006699A (en) * 2016-07-11 2018-01-19 휴먼코스메틱 주식회사 Cosmetic compositions for anti-oxidation, skin whitening or anti-inflammation comprising Tenebrio molitor extracts as an active ingredient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100542266B1 (en) 2003-08-04 2006-01-11 한국식품연구원 Face-pack Composition Comprising Sericin Protein Extracted from Cocoon
KR20110078559A (en) * 2009-12-31 2011-07-07 신면호 Skin care cosmetic composition
KR101429679B1 (en) 2012-05-30 2014-08-13 경북대학교 산학협력단 Cosmetic compositions for skin whitening comprising cricket extracts
KR20180006699A (en) * 2016-07-11 2018-01-19 휴먼코스메틱 주식회사 Cosmetic compositions for anti-oxidation, skin whitening or anti-inflammation comprising Tenebrio molitor extracts as an active ingredient

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230061929A (en) 2021-10-29 2023-05-09 대한민국(환경부 국립생물자원관장) Novel Bacillus endophyticus S2-11 strain
KR102606383B1 (en) 2021-10-29 2023-11-29 대한민국 Novel Bacillus endophyticus S2-11 strain

Similar Documents

Publication Publication Date Title
KR102124200B1 (en) Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising fermented by-product of rice extracts its fractions as effective component
KR101651325B1 (en) Cosmetic composition comprising white rose flower extract for skin whitening and improving skin wrinkle
KR20110054022A (en) Skin-whitening agent, anti-aging agent, and skin-care cosmetic agent
KR20180006699A (en) Cosmetic compositions for anti-oxidation, skin whitening or anti-inflammation comprising Tenebrio molitor extracts as an active ingredient
IL227447A (en) Plant extracts comprising monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
KR20160009752A (en) Composition comprising Dendrobium moniliforme Extract for skin whitening and anti-wrinkle Effects, Functional food and Korean herb cosmetic manufactured by using them
KR20180113108A (en) Composition for skin whitening comprising functional peptide and fermented product
KR101908077B1 (en) Cosmetic composition for whitening, antiaging or skin wrinkle containing natural oriental medicine extracts
Rainer et al. From bench to counter: Discovery and validation of a peony extract as tyrosinase inhibiting cosmeceutical
KR102023571B1 (en) Cosmetic compositions for skin whitening comprising Tenebrio molitor extracts as an active ingredient
KR101047588B1 (en) Whitening composition comprising white rice extract and novel pregnan compound isolated therefrom as active ingredient
KR20180052157A (en) Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry
KR102325393B1 (en) Skin whitening cosmetic composition with bioconversion of Breea segeta extract
KR102022068B1 (en) Method for production of Malpighia emarginata fruit extract without mass destruction of effective compound and cosmetic composition with the extract
KR102000550B1 (en) Composition comprising Polyamine compounds isolated from Quercus Mongolica pollen extracts for whitening
KR102646545B1 (en) Cosmetic composition for skin whitening or skin barrier improvement comprising Hosta longipes extract
KR102301299B1 (en) Skin-lightening Composition Using an Extract of Xanthium canadense
KR20190018100A (en) Cosmetic composition for Antioxidant, anti-wrinkle, anti-inflammatory, skin-whitening and hair-growing active compounds derived from Acorus Calamus Root extract
KR102054132B1 (en) Composition comprising extract of Prasiola japonica for skin whitening
US8309144B2 (en) Use of a cruciferous protein hydrolysate as a depigmentation agent or for a cosmetic and/or pharmaceutical composition
KR20150138875A (en) Composition comprising Water Extract from Panax ginseng C. A. Mayer, Acanthopanax koreanum Nakai and Dendropanax morbifera Leveille for skin whitening, Functional food and Korean herb cosmetic manufactured by using them
KR102034779B1 (en) Cosmetic composition for skin whitening comprising ginsenoside Rh1 and Rg2 and extract of Hydrangea macrophylla
KR102463782B1 (en) A whitening composition and its manufacturing method by bio-renovation of Ligustrum Janponicum Extract
KR20220129921A (en) A whitening composition and its manufacturing method by bio-renovation of Gleditsia japonica
KR20190121091A (en) Whitening composition containing extract, fractions or compound derived from Raphanus sativus L. var niger

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant